These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7067086)

  • 21. Diagnosis and nomenclature of the disorders of the terminal portion of the aldosterone biosynthetic pathway.
    Ulick S
    J Clin Endocrinol Metab; 1976 Jul; 43(1):92-6. PubMed ID: 947946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxygenation of 18-hydroxycorticosterone as the final reaction for aldosterone biosynthesis.
    Kojima I; Ogata E; Inano H; Tamaoki B
    Acta Endocrinol (Copenh); 1984 Nov; 107(3):395-400. PubMed ID: 6507007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 18-hydroxycorticosterone, 18-hydroxycortisol, and 18-oxocortisol in the diagnosis of primary aldosteronism and its subtypes.
    Mulatero P; di Cella SM; Monticone S; Schiavone D; Manzo M; Mengozzi G; Rabbia F; Terzolo M; Gomez-Sanchez EP; Gomez-Sanchez CE; Veglio F
    J Clin Endocrinol Metab; 2012 Mar; 97(3):881-9. PubMed ID: 22238407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of the saline infusion test to diagnose the cause of primary aldosteronism.
    Arteaga E; Klein R; Biglieri EG
    Am J Med; 1985 Dec; 79(6):722-8. PubMed ID: 3907346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enzyme immunoassay for serum 18-hydroxycorticosterone and its clinical application.
    Watanabe F; Ryota T; Kobayashi Y
    Steroids; 1984 May; 43(5):509-16. PubMed ID: 6397877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adrenal steroid responses to ACTH in glucocorticoid-suppressible aldosteronism.
    Ganguly A; Weinberger MH; Guthrie GP; Fineberg NS
    Hypertension; 1984; 6(4):563-7. PubMed ID: 6086520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased 18-hydroxycorticosterone responses to frusemide in essential hypertension.
    Semple PF; Mason PA; Fraser R
    Clin Endocrinol (Oxf); 1980 May; 12(5):473-81. PubMed ID: 7428185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The unique steroidogenesis of the aldosteronoma in the differential diagnosis of primary aldosteronism.
    Ulick S; Blumenfeld JD; Atlas SA; Wang JZ; Vaughan ED
    J Clin Endocrinol Metab; 1993 Apr; 76(4):873-8. PubMed ID: 8473399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [18-hydroxycorticosterone (18-OH -B)].
    Izumi Y
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():322-7. PubMed ID: 16149520
    [No Abstract]   [Full Text] [Related]  

  • 30. [An assay for aldosterone precursors: a tool for clinical diagnosis and adrenal physiopathology].
    Legrand JC; Aupetit B
    Bull Acad Natl Med; 1989 Jun; 173(6):735-9; discussion 739-41. PubMed ID: 2598071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary aldosteronism--a review.
    Menon M; Mersey JH
    Urol Surv; 1980 Aug; 30(4):95-9. PubMed ID: 7001714
    [No Abstract]   [Full Text] [Related]  

  • 32. 21-Deoxyaldosterone excretion in patients with primary aldosteronism and 21-hydroxylase deficiency.
    Lewicka S; Winter J; Bige K; Bokkenheuser V; Vecsei P; Abdelhamid S; Heinrich U
    J Clin Endocrinol Metab; 1987 Apr; 64(4):771-7. PubMed ID: 3493258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correctable subsets of primary aldosteronism. Primary adrenal hyperplasia and renin responsive adenoma.
    Irony I; Kater CE; Biglieri EG; Shackleton CH
    Am J Hypertens; 1990 Jul; 3(7):576-82. PubMed ID: 2194512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma and urine aldosterone to plasma renin activity ratio in the diagnosis of primary aldosteronism.
    Bernini G; Moretti A; Orlandini C; Berti P; Miccoli P; Bardini M; Taurino C; Bernini M; Salvetti A
    J Hypertens; 2008 May; 26(5):981-8. PubMed ID: 18398341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity.
    Schwartz GL; Turner ST
    Clin Chem; 2005 Feb; 51(2):386-94. PubMed ID: 15681560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time course of plasma corticosterone, 18-hydroxycorticosterone and aldosterone concentrations following CRF administration in the rat. A phase of corticosterone inhibition.
    Maser-Gluth C; Toygar A; Vecsei P
    Life Sci; 1984 Aug; 35(8):879-84. PubMed ID: 6090854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 21-Deoxytetrahydroaldosterone excretion in primary hyperaldosteronism.
    Abdelhamid S; Lewicka S; Vecsei P; Winter J
    Cardiology; 1985; 72 Suppl 1():102-6. PubMed ID: 4053120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aldosterone testing: evaluation of a novel automated immunoassay.
    Derlet F; Lepoutre T; Gruson D
    Biomarkers; 2014 Feb; 19(1):86-91. PubMed ID: 24289850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary 18,19-dihydroxycorticosterone and 18-hydroxy-19-norcorticosterone excretion in patients with primary and secondary aldosteronism.
    Takeda Y; Bige K; Iwuanyanwu T; Lewicka S; Vecsei P; Abdelhamid S; Harnik M
    Steroids; 1991 Nov; 56(11):566-70. PubMed ID: 1814024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Responsiveness of plasma 18-hydroxycorticosterone and aldosterone to angiotensin II or corticotropin in nonazotemic diabetes mellitus.
    Beretta-Piccoli C; Weidmann P; Fraser R
    Diabetes; 1983 Jan; 32(1):1-5. PubMed ID: 6293899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.